0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 1,976 1,976 395 395 1,581 xbrli:pure xbrli:shares iso4217:GBP 14577936 2024-04-01 2024-12-31 14577936 2024-12-31 14577936 2024-03-31 14577936 2023-01-09 2024-03-31 14577936 2024-03-31 14577936 2023-01-08 14577936 bus:Director1 2024-04-01 2024-12-31 14577936 core:WithinOneYear 2024-03-31 14577936 core:ShareCapital 2024-12-31 14577936 core:ShareCapital 2024-03-31 14577936 core:RetainedEarningsAccumulatedLosses 2024-12-31 14577936 core:RetainedEarningsAccumulatedLosses 2024-03-31 14577936 bus:SmallEntities 2024-04-01 2024-12-31 14577936 bus:AuditExemptWithAccountantsReport 2024-04-01 2024-12-31 14577936 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2024-12-31 14577936 bus:PrivateLimitedCompanyLtd 2024-04-01 2024-12-31 14577936 bus:FullAccounts 2024-04-01 2024-12-31 14577936 core:OfficeEquipment 2024-04-01 2024-12-31 14577936 core:OfficeEquipment 2024-03-31
COMPANY REGISTRATION NUMBER: 14577936
SKD CARE LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 December 2024
SKD CARE LIMITED
STATEMENT OF FINANCIAL POSITION
31 December 2024
31 Dec 24
31 Mar 24
Note
£
£
£
£
FIXED ASSETS
Tangible assets
4
1,581
CURRENT ASSETS
Cash at bank and in hand
19,797
CREDITORS: Amounts falling due within one year
5
10,210
----
--------
NET CURRENT ASSETS
9,587
----
--------
TOTAL ASSETS LESS CURRENT LIABILITIES
11,168
----
--------
NET ASSETS
11,168
----
--------
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
( 100)
11,068
----
--------
SHAREHOLDERS FUNDS
11,168
----
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
SKD CARE LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
31 December 2024
These financial statements were approved by the board of directors and authorised for issue on 26 February 2025 , and are signed on behalf of the board by:
Dr S Duggal
Director
Company registration number: 14577936
SKD CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
PERIOD FROM 1 APRIL 2024 TO 31 DECEMBER 2024
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Fulford Lodge, 1 Heslington Lane, Fulford, York, YO10 4HW.
2. STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland.'
3. ACCOUNTING POLICIES
(a) Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
(b) Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a break-up basis. As of 31 December 2024, the company has opted to be voluntary struck off at companies house and will cease training.
(c) Revenue recognition
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year-end date is recognised by reference to the stage of completion.
(d) Current & deferred tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
(e) Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
(f) Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
20% reducing balance
(g) Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
(h) Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities, or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. TANGIBLE ASSETS
Equipment
£
Cost
At 1 April 2024
1,976
Disposals
( 1,976)
-------
At 31 December 2024
-------
Depreciation
At 1 April 2024
395
Disposals through business combinations
( 395)
-------
At 31 December 2024
-------
Carrying amount
At 31 December 2024
-------
At 31 March 2024
1,581
-------
5. CREDITORS: Amounts falling due within one year
31 Dec 24
31 Mar 24
£
£
Accruals and deferred income
403
Corporation tax
9,174
Directors current account
633
----
--------
10,210
----
--------
6. RELATED PARTY TRANSACTIONS
During the year the Directors made available loans to the Company. At the year end the balance of the loan was £ 654 (2024: £ 634 ). Interest has been charged at the UK market rate.